Skip to main content

Month: February 2021

DIGITALIST GROUP -KONSERNIN TILINPÄÄTÖSTIEDOTE 1.1.-31.12.2020

DIGITALIST GROUP OYJ    TILINPÄÄTÖSTIEDOTE    26.2.2021 KLO. 9.00DIGITALIST 2020YHTEENVETOLokakuu – joulukuu 2020 (vuoden 2019 vertailuluvut suluissa):●        Liikevaihto 5,0 milj. euroa (6,7 milj. euroa), laskua -25,0%.●        Käyttökate (EBITDA) 0,3 milj. euroa (-1,7 milj. euroa), 5,6% liikevaihdosta (-24,9%).●        Liiketulos* -0,9 milj. euroa (-9,5 milj. euroa), -17,5% liikevaihdosta (-140,9%).●        Nettotulos* -1,6 milj. euroa (-9,5 milj. euroa), -32,0% liikevaihdosta (-140,4%)●        Tulos per osake (laimennettu ja laimentamaton) -0,00 euroa (-0,02 euroa).*Vertailu vuoden liiketulos ja nettotulos sisältävät liikearvon alaskirjauksen -7.0 milj. euroa.Tilikausi tammikuu – joulukuu 2020 (vuoden 2019 vertailuluvut suluissa):●        Liikevaihto 20,5 milj. euroa (27,4 milj. euroa), laskua -25,2%.●        Käyttökate (EBITDA)...

Continue reading

NEXSTIM PLC FINANCIAL STATEMENTS RELEASE 2020

Company announcement, Helsinki, 26 February 2021 at 9:00 am (EET)NEXSTIM PLC FINANCIAL STATEMENTS RELEASE 2020Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”), today provides its financial statements for the full year 2020 (1 January–31 December 2020) and H2 2020 (1 July-31 December 2020).Highlights, July – December 2020Continued to minimize the effect of COVID-19 pandemic as well as focusing on generating profitable revenue growth. Considering the difficult business environment, excellent progress with 9 new NBS systems sold, 3 in the US 6 in the EU and rest of the world. Total of 3 new NBT® systems installed to clinics in the US and Europe, across multiple sites, for the treatment of Major Depressive Disorder (MDD) July 1 – December 31, 2020 was the Company’s best reported second half to date when...

Continue reading

NEXSTIM OYJ:N TILINPÄÄTÖSTIEDOTE 2020

Yhtiötiedote, Helsinki, 26.2.2021 klo 9.00NEXSTIM OYJ:N TILINPÄÄTÖSTIEDOTE 2020Nexstim Oyj (NXTMH:HEX, NXTMS:STO) (”Nexstim” tai ”Yhtiö”) julkistaa tänään koko tilikauden 2020 (1.1.–31.12.2020) tilinpäätöksensä sekä vuoden 2020 jälkipuoliskon (1.7.–31.12.2020).Kohokohdat heinä-joulukuussa 2020COVID-19 pandemian vaikutusten minimointia jatkettiin samalla keskittyen luomaan kannattavaa liikevaihdon kasvua. Vaikea liiketoimintaympäristö huomioiden, myynnissä saavutettiin erinomaista kehitystä 9 uuden NBS laitteistomyynnin myötä. Uusista laitteistoista 3 myytiin Yhdysvaltoihin ja 6 EU-alueelle ja muualle maailmaan. Yhteensä 3 uutta NBT® laitteistoa asennettiin useisiin sairaaloihin ja klinikoihin Yhdysvaltoihin ja Eurooppaan vakavan masennuksen (MDD) hoitoon. 01.07.-31.12.2021 oli Yhtiön tähän mennessä paras raportoitu toinen vuosipuolisko...

Continue reading

NEXSTIM ABP:S BOKSLUTSKOMMUNIKÉ 2020

Företagsmeddelande, Helsingfors den 26 februari 2021 kl. 9.00NEXSTIM ABP:S BOKSLUTSKOMMUNIKÉ 2020Nexstim Abp (NXTMH:HEX, NXTMS:STO) (”Nexstim” eller ”bolaget”) rapporterar i dag om bokslutet för hela räkenskapsperioden 2020 (1/1–31/12 2020) samt andra halvåret 2020 (1/7–31/12 2020).Viktiga händelser, juli–december 2020Bolaget fortsatte åtgärderna för att minimera effekterna av covid-19-pandemin och fokuserade på att generera lönsam ökning av omsättningen. Med tanke på den svåra affärsmiljön gjorde bolaget utmärkta framsteg genom att sälja nio nya NBS-system, varav tre levererades till USA och sex till EU och den övriga världen. Sammanlagt tre nya NBT®-system installerades på olika anläggningar i USA och Europa för behandling av egentlig depression (MDD). Halvåret 1/7–31/12 2020 var bolagets bästa andra halvår någonsin, mätt i omsättning...

Continue reading

Abcam to Report Interim Results on Monday, March 8, 2021

CAMBRIDGE, United Kingdom, Feb. 26, 2021 (GLOBE NEWSWIRE) — Abcam plc (AIM: ABC; Nasdaq: ABCM) (“Abcam” or the “Company”), a global leader in the supply of life science research tools, will report its Interim Results for the six-month period ended 31 December 2020 at 12.00 p.m. GMT (7.00 a.m. EST) on Monday, March 8, 2021.Following the announcement, the Company will host a live teleconference and webcast at 2:00 p.m. GMT (9:00 a.m. EST) that same day (details below).To access the webcast, please use the following link: https://edge.media-server.com/mmc/p/zejeosdnTo participate in the call, please find details below:The press release and the live audio webcast will also be available in the investor section of Abcam’s corporate website at corporate.abcam.com/investors/reports-presentations/. An archive will be available after the call...

Continue reading

Olainfarm Group lays a strong foundation for sustainable development

Olainfarm Group’s profit in 2020 reached EUR 9.5 million and the parent company closed the year 2020 with 11.5 million EUR profitThe Management Board will propose to approve a dividend payout of EUR 0.17 per share in the annual report of 2020, which is a total of EUR 2 394 463Significant investments are planned for research and development, as well as the acquisition of products and modernization and digitalization“Covid-19 is having a significant impact on the global healthcare and pharmaceutical industries. Our values ​​and care for the society remain unchanged in this difficult time, we strive to improve people’s health and quality of life. In accordance with the Olainfarm Group’s five-year strategy “Forward”, in 2020 an unprecedented transformation of the Group was initiated with the goal of making internal...

Continue reading

Olainfarm grupa izveido spēcīgu pamatu ilgtspējīgai attīstībai

Olainfarm grupas peļņa 2020. gadā sasniedz 9.5 milj. EUR, un mātes uzņēmums 2020. gadu noslēdza ar 11.5 milj. EUR peļņuValde rosinās 2020. gada pārskatā apstiprināt dividenžu izmaksu 0.17 EUR par vienu akciju, kas kopumā ir  2 394 463 EURPlānotas nozīmīgas investīcijas jaunu produktu pētniecībā un attīstībā, kā arī iegādē un uzņēmuma modernizācijā un digitalizācijā“Covid-19 būtiski ietekmē veselības un farmācijas nozari visā pasaulē. Mūsu vērtības un rūpes par sabiedrību šajā sarežģītajā laikā paliek nemainīgas – uzlabot cilvēku veselību un dzīves kvalitāti.  Saskaņā ar Olainfarm grupas piecgades stratēģiju “Uz priekšu”, 2020. gadā ir uzsākta vēl nebijusi Grupas transformācija ar mērķi efektivizēt iekšējos procesus ilgtspējīgai izaugsmei. Neskatoties uz Covid-19 izaicinājumiem, mums ir izdevies izveidot spēcīgu pamatu. Nostiprināt un...

Continue reading

Bergman & Beving AB: CEO of Bergman & Beving AB, Pontus Boman, hands over to Magnus Söderlind as of the 1st of May 2021

Press releaseCEO of Bergman & Beving AB, Pontus Boman, hands over to Magnus Söderlind as of the 1st of May 2021Pontus Boman has since the split from Momentum Group in 2017 led the transformation of Bergman & Beving in a meritorious way. This has created three strong divisions with independent product and brand companies in a decentralised structure.In order to strengthen the management before the next step in this transformation, the Board of Directors in agreement with Pontus has decided to recruit Magnus Söderlind as new President and CEO of Bergman & Beving. After 13 years in Lagercrantz Group, Magnus is well acquainted with the decentralised work method and focus on niche product companies which the future for Bergman & Beving entails.This change means a strengthening of management where Pontus moves to the role...

Continue reading

Bergman & Beving AB: Vd för Bergman & Beving AB, Pontus Boman, lämnar över till Magnus Söderlind per den första maj 2021

PressmeddelandeVd för Bergman & Beving AB, Pontus Boman, lämnar över till Magnus Söderlind per den första maj 2021Pontus Boman har sedan delningen från Momentum Group år 2017 på ett förtjänstfullt sätt lett omställningen av Bergman & Beving. Det har skapat tre starka divisioner med fristående produkt- och varumärkesbolag i en decentraliserad struktur.För att stärka ledningen inför nästa steg i detta förändringsarbete har styrelsen i samförstånd med Pontus beslutat att rekrytera Magnus Söderlind som ny verkställande direktör och koncernchef för Bergman & Beving. Magnus är efter 13 år på Lagercrantz Group väl förtrogen med det decentraliserade arbetssättet och fokus på nischade produktbolag som Bergman & Bevings framtid innebär.Förändringen innebär en ledningsförstärkning där Pontus övergår till rollen som vice verkställande...

Continue reading

Bourse Direct : Volume d’ordres exécutés en hausse de 121,2% Résultat d’exploitation de 9,7 millions d’euros (+372,8%) Résultat net en hausse à 6,1 millions d’euros (+341,6%) Recrutement record de nouveaux comptes en croissance de 116%

Forte croissance de l’activité en 2020 :Volume d’ordres exécutés en hausse de 121,2%Résultat d’exploitation de 9,7 millions d’euros (+372,8%)Résultat net en hausse à 6,1 millions d’euros (+341,6%)Recrutement record de nouveaux comptes en croissance de 116%Bourse Direct proposera la distribution d’un dividende de 5 centimes par action à la prochaine Assemblée générale                                 * Les variations sont calculées sur les montants en euro.Dans un contexte de crise sanitaire sans précédent, les marchés boursiers ont connu une très forte volatilité au cours de l’année 2020.  Bourse Direct enregistre ainsi plus de 6,6 millions d’ordres exécutés en 2020 pour sa clientèle directe, en croissance 121,2% par rapport à l’année précédente. Le nombre de nouveaux clients recrutés connaît une année record en croissance de 116%, démontrant...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.